Abstract: The present invention relates to heteroaromatic chalcone derivatives, particularly the compounds of formula (I) as described and defined herein, pharmaceutical compositions comprising these compounds, and their medical use, including their use in the treatment or prevention of cancer and, in particular, in the treatment or prevention of hematologic malignancies.

Abstract: A process for production of acrylic acid includes preparing a product gas mixture by a catalytic gas-phase oxidation of a C3 precursor; cooling and contacting the cooled product gas mixture in an absorption column having at least two cooling loops in countercurrent with an absorbent to obtain an absorbate A, containing the absorbent and absorbed acrylic acid; condensing a high boiler fraction of the product gas mixture in a first cooling loop; condensing a low boiler fraction of the product gas mixture in a second cooling loop; maintaining a temperature of the absorbate A in the second cooling loop at a value of at least 56° C.; removing an acid water stream comprising glyoxal from the absorption column at a side take-off located above the second cooling loop; and removing a stream F of absorbate A from the absorption column at a side take-off, located at a height of the absorption column between the first cooling loop and the second cooling loop.

Abstract: The present invention relates to heteroaromatic chalcone derivatives, particularly the compounds of formula (I) as described and defined herein, pharmaceutical compositions comprising these compounds, and their medical use, including their use in the treatment or prevention of cancer and, in particular, in the treatment or prevention of hematologic malignancies.

Abstract: The invention is related to a process for production of acrylic acid comprising the following steps: a) preparation of a product gas mixture by a catalytic gas-phase oxidation of at least one C3 precursor compound to acrylic acid, wherein acrylic acid is formed as a main product of the catalytic gas-phase oxidation and glyoxal is formed as a by-product and the product gas mixture comprises acrylic acid and glyoxal, b) cooling of the product gas mixture, c) contacting the product gas mixture in countercourrent with an absorbent, wherein an absorbate A, comprising the absorbent and absorbed acrylic acid, is formed, d) introducing a feed stream F (2) comprising at least part of the absorbate A into a rectification column comprising a rectifying section and a stripping section, e) enriching the absorbent in the stripping section and enriching acrylic acid in the rectifying section, f) withdrawing a stream C of crude acrylic acid comprising at least 90% by weight of acrylic acid out of the rectifying section as a

Abstract: A continuous process for preparing (meth)acrylates of C10-alcohol mixtures by reaction of glacial (meth)acrylic acid with an isomer mixture of C10-alcohols composed of 2-propylheptanol as the main isomer and at least one of the C10-alcohols 2-propyl-4-methylhexanol, 2-propyl-5-methylhexanol, 2-isopropylheptanol, 2-isopropyl-4-methylhexanol, 2-isopropyl-5-methylhexanol and/or 2-propyl-4,4-dimethylpentanol, and the use of a diester of dicarboxylic acids which have been esterified with N-oxyl-containing compounds as polymerization inhibitors in such a process.

Abstract: A process for inhibiting unwanted free-radical polymerization of acrylic acid present in a liquid phase P whose acrylic acid content is at least 10% by weight and which, based on the weight of the acrylic acid present therein, additionally comprises at least 100 ppm by weight of propionic acid and at least 100 ppm by weight of glyoxal, in which at least one chemical compound of the element copper is added to the liquid phase P, and the resulting liquid phases P to which a chemical compound of the element copper has been added.

Abstract: In a method of stabilizing acrylic compounds, a liquid phase containing at least one acrylic compound is mixed with at least one metal and at least one ligand. The acrylic compound can be acrylic acid, methacrylic acid, and their respective esters. The metal can be copper, manganese, and cerium. The ligand can be a quinoline compound of formula (I), an N-oxide of a compound of formula (I), 2,2?-bis(2,3-dihydro-3-oxoindolylidene), or an aliphatic y-dentate ligand with y being 2-6 and comprising at least two nitrogen atoms joined by aliphatic or aromatic C1-C4 bridges comprising y-2 further coordinating nitrogen atoms or heteroatoms: where X is OH, NH2, O—(C1-C4)-alkyl, O—C(O)—(C1-C4)-alkyl, or O—C(O)-phenyl; R1 is H, or (C1-C4)-alkyl; R2 is H, (C1-C4)-alkyl, Cl, Br, or SO3H; and R3 is H, Cl or Br.

Abstract: A process for inhibiting unwanted free-radical polymerization of acrylic acid present in a liquid phase P whose acrylic acid content is at least 10% by weight and which, based on the weight of the acrylic acid present therein, additionally comprises at least 100 ppm by weight of propionic acid and at least 100 ppm by weight of glyoxal, in which at least one chemical compound of the element copper is added to the liquid phase P, and the resulting liquid phases P to which a chemical compound of the element copper has been added.

Abstract: In a method of stabilizing acrylic compounds, a liquid phase containing at least one acrylic compound is mixed with at least one metal and at least one ligand. The acrylic compound can be acrylic acid, methacrylic acid, and their respective esters. The metal can be copper, manganese, and cerium. The ligand can be a quinoline compound of formula (I), an N-oxide of a compound of formula (I), 2,2?-bis(2,3-dihydro-3-oxoindolylidene), or an aliphatic y-dentate ligand with y being 2-6 and comprising at least two nitrogen atoms joined by aliphatic or aromatic C1-C4 bridges comprising y-2 further coordinating nitrogen atoms or heteroatoms: where X is OH, NH2, O—(C1-C4)-alkyl, O—C(O)—(C1-C4)-alkyl, or O—C(O)-phenyl; R1 is H, or (C1-C4)-alkyl; R2 is H, (C1-C4)-alkyl, Cl, Br, or SO3H; and R3 is H, Cl or Br.

Abstract: A continuous process for preparing (meth)acrylates of C10-alcohol mixtures by reaction of glacial (meth)acrylic acid with an isomer mixture of C10-alcohols composed of 2-propylheptanol as the main isomer and at least one of the C10-alcohols 2-propyl-4-methylhexanol, 2-propyl-5-methylhexanol, 2-isopropylheptanol, 2-isopropyl-4-methylhexanol, 2-isopropyl-5-methylhexanol and/or 2-propyl-4,4-dimethylpentanol, and the use of a diester of dicarboxylic acids which have been esterified with N-oxyl-containing compounds as polymerization inhibitors in such a process.

Abstract: A process for inhibiting polymerization of (meth)acrylic acid and/or (meth)acrylic esters by introducing an oxygenous gas into the (meth)acrylic acid and/or the (meth)acrylic ester, in which the (meth)acrylic acid and/or the (meth)acrylic ester has a degree of purity of at least 95% and is in the liquid state.

Abstract: A method for producing a selective doping structure in a semiconductor substrate in order produce a photovoltaic solar cell. The method includes the following steps: A) applying a doping layer (2) to the emitter side of the semiconductor substrate, B) locally heating a melting region of the doping layer (2) and a melting region of the semiconductor substrate lying under the doping layer (2) in such a way that dopant diffuses from the doping layer (2) into the melted semiconductor substrate via liquid-liquid diffusion, so that a high doping region (3) is produced after the melt mixture solidifies, C) producing the planar low doping region by globally heating the semiconductor substrate, D) removing the doping layer (2) and E) removing or converting a layer of the semiconductor substrate on the doping side in such a way that part of the low doping region and of the high doping region close to the surface is removed or is converted into an electrically non-conducting layer.

Abstract: The present invention relates to vinylogous chalcone derivatives, in particular the compounds of formula (I) as described and defined herein, pharmaceutical compositions comprising these compounds, and their medical use, including their use in the treatment or prevention of cancer, in particular malignant hematological diseases/disorders.

Abstract: A process for separating acrylic acid present as a main product and glyoxal present as a by-product in a product gas mixture of a partial gas phase oxidation of a C3 precursor compound, in which a liquid phase P is obtained, which consists of acrylic acid to an extent of at least 70% of its weight and, based on the molar amount of acrylic acid present therein, comprises at least 200 molar ppm of glyoxal, in which the glyoxal is separated from the acrylic acid in the liquid phase P by crystallization.

Abstract: A process for inhibiting unwanted free-radical polymerization of acrylic acid present in a liquid phase P whose acrylic acid content is at least 10% by weight and which, based on the weight of the acrylic acid present therein, additionally comprises at least 100 ppm by weight of propionic acid and at least 100 ppm by weight of glyoxal, in which at least one chemical compound of the element copper is added to the liquid phase P, and the resulting liquid phases P to which a chemical compound of the element copper has been added.

Abstract: A process for inhibiting polymerization of (meth)acrylic acid and/or (meth)acrylic esters by introducing an oxygenous gas into the (meth)acrylic acid and/or the (meth)acrylic ester, in which the (meth)acrylic acid and/or the (meth)acrylic ester has a degree of purity of at least 95% and is in the liquid state.

Abstract: A process for removal of a crude acrylic acid from a product gas mixture which comprises glyoxal as a by-product from a heterogeneously catalyzed partial gas phase oxidation of at least one C3 precursor compound, which comprises the absorption of the acrylic acid in a high-boiling absorbent and the rectificative workup of the resulting adsorbate, and in which absorbent present in the bottoms liquid withdrawn from the bottom space of the absorption column is distilled off in a distillation unit and recycled into the absorption, before high boilers which remain are discharged, and in which the glyoxal content of the crude acrylic acid is reduced by restricting the high boiler residence time in the distillation unit.

Abstract: A process for transferring heat to a liquid mixture comprising at least one (meth)acrylic monomer in an indirect heat exchanger, wherein a quaternary ammonium salt, a tertiary amine or a salt thereof with a Brønsted acid is added to the liquid mixture to reduce fouling.

Abstract: A process for separating acrylic acid present as a main product and glyoxal present as a by-product in a product gas mixture of a partial gas phase oxidation of a C3 precursor compound, in which a liquid phase P is obtained, which consists of acrylic acid to an extent of at least 70% of its weight and, based on the molar amount of acrylic acid present therein, comprises at least 200 molar ppm of glyoxal, in which the glyoxal is separated from the acrylic acid in the liquid phase P by crystallization.

Abstract: A separating column containing a sequence of mass transfer trays that are supported by at least one covered double-T support and/or covered U-shaped support.